Mark was Vice President, Medical Operations and Patient Advocacy at Kiniksa Pharmaceuticals, and Vice President, Medical Affairs at Aeglea BioTherapeutics. Mark Bechter joined Avanzanite Bioscience in 2025.
Mark Bechter is currently
Create your alert
to follow the career of Mark Bechter.
Do you need to know more about Mark Bechter? More results.
Report an error
Update the org chart details of Mark Bechter.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.